Gilead Sciences Inc GILD Schedules Participation at Four Leading Q2 2026 Healthcare Investor Conferences to Update Stakeholders on Pipeline and Operational Milestones The Charles Schwab Corporation SCHW Bullish LongTerm Growth Outlook Persists Despite Modest Price Target Cuts PostQ1 2026 Earnings Poet Technologies Inc POET AI Optics Play Plunges 178 on Contract Cancellation Dip Buying Opportunity or Speculative Trap EWCZ European reports 63 percent EPS surprise for Q4 2025 shares stay flat on no disclosed revenue figures The Southern Company SO HeadToHead Utility Sector Valuation Comparison With Vistra Corp VST For 2026 LBRX LB Pharmaceuticals posts slightly smaller Q4 2025 loss than analyst estimates shares rise 366 percent The valuation case for Chagee CHA that is hard to ignore Selling Pressure 20260503 EP Empire drops 069 after Q3 2025 earnings release with no consensus estimate benchmarks for comparison Duke Energy Corporation DUK PreEarnings Analysis Favorable Odds of Q1 2026 EPS Beat Amid Defensive Sector Tailwinds ORIO Orion posts narrower than expected Q4 2025 loss yet shares drop 189 percent in todays trading